Invention Application
WO2004005461A3 ANTISENSE MODULATION OF INSULIN-LIKE GROWTH FACTOR 2 EXPRESSION
审中-公开
胰岛素样生长因子2表达的抗原调节
- Patent Title: ANTISENSE MODULATION OF INSULIN-LIKE GROWTH FACTOR 2 EXPRESSION
- Patent Title (中): 胰岛素样生长因子2表达的抗原调节
-
Application No.: PCT/US0320309Application Date: 2003-06-25
-
Publication No.: WO2004005461A3Publication Date: 2004-11-04
- Inventor: BHANOT SANJAY , DOBIE KENNETH W
- Applicant: ISIS PHARMACEUTICALS INC , BHANOT SANJAY , DOBIE KENNETH W
- Assignee: ISIS PHARMACEUTICALS INC,BHANOT SANJAY,DOBIE KENNETH W
- Current Assignee: ISIS PHARMACEUTICALS INC,BHANOT SANJAY,DOBIE KENNETH W
- Priority: US18877702 2002-07-02
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07H21/04 ; C12N15/113 ; C07H21/02 ; A61K48/00 ; C12N15/86 ; C12P19/34
Abstract:
Antisense compounds, compositions and methods are provided for modulating the expression of insulin-like growth factor 2. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding insulin-like growth factor 2. Methods of using these compounds for modulation of insulin-like growth factor 2 expression and for treatment of diseases associated with expression of insulin-like growth factor 2 are provided.
Information query
IPC分类:
